The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Hurts, who hasn't played since Dec. 22 due to a concussion, practiced on a limited basis Wednesday ahead of Sunday's wild-card game between Philadelphia and Green Bay. He remains in concussion ...

After missing the last two weeks with a concussion that he suffered in Week 16, Jalen Hurts was back on the practice field for Philadelphia on Thursday. It was a big step for the quarterback ...

(AP Photo/Charlie Riedel) KANSAS CITY, Mo. (AP) — Chiefs safety Bryan Cook was evaluated for a concussion but was allowed to return to their playoff game against Houston on Saturday, while and Texans ...